Consistent with its ability to inactivate RAP1, RAP1GAP is a tumor suppressor in several human cancers, including endometrial (51), thyroid (52, 53), pancreas (54), colon (55), melanomas (56), prostate (57), and head and neck carcinomas (58). The gene discussed is RAP1GAP; the disease is cancer.